Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Mesylate trihydrate salt of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihy dro-2(1H)-indol-2-one (=ziprasidone), its preparation and its use as dopamine D2 antagonist

US Patent 6110918 · Granted Aug 29, 2000

Estimated economic value: $295,433,000

Assignee

Inventors

View full patent text on Google Patents →